Key result
The PQRST score, derived from standard 12-lead ECG patterns, successfully predicted left ventricular ejection fraction < 40% in NSTE-ACS patients with an AUC of 0.824 in the derivation cohort and 0.899 in the validation cohort.
Why the study?
Few studies have characterized electrocardiography patterns correlated with left ventricular systolic dysfunction in patients with NSTE-ACS.
Does the ECG-derived PQRST score predict LVEF < 40% and 24-month all-cause mortality in patients with NSTE-ACS?
Cohort (n=466)
No
Does the ECG-derived PQRST score predict LVEF < 40% and 24-month all-cause mortality in patients with NSTE-ACS?
Effect estimate: AUC 0.824 (95% CI 0.768-0.880)
The novel ECG-derived PQRST score accurately predicts LVEF < 40% and provides additive prognostic value for 24-month mortality in patients with NSTE-ACS, facilitating early risk stratification.
ECG scores may aid LV dysfunction prediction in NSTE-ACS; leaves open prospective validation before clinical use.
Background: Few studies have characterized electrocardiography (ECG) patterns correlated with left ventricular (LV) systolic dysfunction in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS). Objectives: This study aims to develop ECG pattern-derived scores to predict LV systolic dysfunction in NSTE-ACS patients. Methods: A total of 466 patients with NSTE-ACS were retrospectively enrolled. LV ejection fraction (LVEF) was assessed by echocardiography within 72 h after the first triage ECG acquisition; there was no coronary intervention in between. ECG score was developed to predict LVEF < 40%. Performance of LVEF, the Global Registry of Acute Coronary Events (GRACE), Thrombolysis in Myocardial Infarction (TIMI) and ECG scores to predict 24-month all-cause mortality were analyzed. Subgroups with varying LVEF, GRACE and TIMI scores were stratified by ECG score to identify patients at high risk of mortality. Results: LVEF < 40% was present in 20% of patients. We developed the PQRST score by multivariate logistic regression, including p oor R wave progression, Q RS duration > 110 ms, heart r ate > 100 beats per min, and ST- segment depression ≥ 1 mm in ≥ 2 contiguous leads, ranging from 0 to 6.5. The score had an area under the curve (AUC) of 0.824 in the derivation cohort and 0.899 in the validation cohort for discriminating LVEF < 40%. A PQRST score ≥ 3 could stratify high-risk patients with LVEF ≥ 40%, GRACE score > 140, or TIMI score ≥ 3 regarding 24-month all-cause mortality. Conclusions: The PQRST score could predict LVEF < 40% in NSTE-ACS patients and identify patients at high risk of mortality in the subgroups of patients with LVEF ≥ 40%, GRACE score > 140 or TIMI score ≥ 3.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2022) conducted a cohort in Non-ST segment elevation acute coronary syndrome (NSTE-ACS) (n=466). PQRST score (ECG pattern-derived score) vs. PQRST score < 3 was evaluated on Left ventricular ejection fraction (LVEF) < 40% (AUC 0.824, 95% CI 0.768-0.880). The PQRST score, derived from standard 12-lead ECG patterns, successfully predicted left ventricular ejection fraction < 40% in NSTE-ACS patients with an AUC of 0.824 in the derivation cohort and 0.899 in the validation cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: